These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11753970)

  • 1. Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors.
    Toretsky JA; Steinberg SM; Thakar M; Counts D; Pironis B; Parente C; Eskenazi A; Helman L; Wexler LH
    Cancer; 2001 Dec; 92(11):2941-7. PubMed ID: 11753970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.
    Borinstein SC; Barkauskas DA; Krailo M; Scher D; Scher L; Schlottmann S; Kallakury B; Dickman PS; Pawel BR; West DC; Womer RB; Toretsky JA
    Cancer; 2011 Nov; 117(21):4966-76. PubMed ID: 21480204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study.
    Borinstein SC; Barkauskas DA; Bernstein M; Goorin A; Gorlick R; Krailo M; Schwartz CL; Wexler LH; Toretsky JA
    Pediatr Blood Cancer; 2014 Apr; 61(4):749-52. PubMed ID: 24178953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.
    Rodriguez-Galindo C; Poquette CA; Daw NC; Tan M; Meyer WH; Cleveland JL
    Med Pediatr Oncol; 2001 Jun; 36(6):605-11. PubMed ID: 11344491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
    Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
    Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y; Sakai H; Hayashi T; Kanetake H
    Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
    Shariat SF; Lamb DJ; Kattan MW; Nguyen C; Kim J; Beck J; Wheeler TM; Slawin KM
    J Clin Oncol; 2002 Feb; 20(3):833-41. PubMed ID: 11821468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
    Holdaway IM; Mason BH; Lethaby AE; Singh V; Harvey VJ; Thompson PI; Evans BD
    ANZ J Surg; 2003 Nov; 73(11):905-8. PubMed ID: 14616567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer.
    Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
    Tumour Biol; 2014 Sep; 35(9):9303-9. PubMed ID: 24943688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
    Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
    Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
    Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
    Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.
    Toriola AT; Ziegler M; Li Y; Pollak M; Stolzenberg-Solomon R
    Ann Surg Oncol; 2017 Oct; 24(11):3212-3219. PubMed ID: 28681154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.
    Karna E; Surazynski A; Orłowski K; Łaszkiewicz J; Puchalski Z; Nawrat P; Pałka J
    Int J Exp Pathol; 2002 Oct; 83(5):239-45. PubMed ID: 12641820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
    Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
    Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs.
    Song DW; Ro WB; Sur JH; Seung BJ; Kang HM; Kim JW; Park SH; Park HM
    J Vet Sci; 2021 Nov; 22(6):e77. PubMed ID: 34697923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.